Most pharmacies ship GLP-1 medications in insulated packaging with cold packs
Semaglutide and tirzepatide are still under patent, meaning any company that imports the peptides or makes copies is breaking the law, says Stavros Nicolaou, Head of Strategic Trade at Aspen Pharmacare , which has a licensing deal with Eli Lilly to market Mounjaro in South Africa
Injectable GLP-1 agonists are associated with injection site reactions in 3-10% of users, including pain, erythema, and nodule formation
Semaglutide has a prolonged half-life of approximately one week, allowing for once-weekly subcutaneous administration in its injectable forms
Retrieved from Encarnao, I
Effect of orlistat on plasma lipids and body weight: a systematic review and meta-analysis of 33 randomized controlled trials